Abstract:A one‐pot commercial strip‐assisted CRISPR‐enabled microfluidic assay, called RECOGNIZER (Re‐building commercial pregnancy strips via large‐size nanoflowers) is designed for the multiplexed sample‐to‐answer quantification of human respiratory viruses using a custom‐built app. By employing DNA nanoflowers with a large surface‐to‐volume ratio and well‐defined surfaces, the probe loading density is increased, achieving a remarkable signal‐to‐noise ratio exceeding tenfold at 1 nM target. The absence of sensitive, multiplexed, and point‐of‐care assays poses a critical obstacle in promptly responding to emerging human respiratory virus (HRV) pandemics. Herein, RECOGNIZER (re‐building commercial pregnancy strips via large‐size nanoflowers), an innovative one‐pot CRISPR assay, is presented that employs commercially available strips to identify several types of HRVs. The superiority of the RECOGNIZER assay mainly relies on two aspects: (i) DNA nanoflowers possessing a high surface‐to‐volume ratio and well‐defined surface allow for a considerable probe loading density and minimized non‐specific interaction, achieving an impressive signal‐to‐noise proportion exceeding tenfold at 1 nM target. (ii) The design of the one‐pot reaction, multi‐channel chip, and custom‐made app enables the rapid, sample‐to‐answer, and multiplexed analysis of four HRVs in 25 min. This assay demonstrates a sensitivity of 5.42 pM for synthetic SARS‐CoV‐2 RNA and 10 copies μL−1 for SARS‐CoV‐2 plasmids after pre‐amplification. Finally, the proposed approach indicated 100% accuracy in 50 clinical swab samples, demonstrating the robust performance in distinguishing SARS‐CoV‐2 from other HRVs. The versatility and scalability of RECOGNIZER renders it a user‐friendly platform for virus infection monitoring, offering significant potential for improving pandemic response efforts.

Sensitive and Rapid Diagnosis of Respiratory Virus Coinfection Using a Microfluidic Chip‐Powered CRISPR/Cas12a System (Small 26/2022)

Sensitive and Rapid Diagnosis of Respiratory Virus Coinfection Using a Microfluidic Chip‐Powered CRISPR/Cas12a System

CRISPR/Cas12a-Assisted isothermal amplification for rapid and specific diagnosis of respiratory virus on an microfluidic platform

An integrated dual-layer microfluidic platform for multiple respiratory viruses screening

Rapid and Accurate Detection of SARS-CoV-2 Using an Ipad-Controlled, High-Throughput, Portable, and Multiplex Hive-Chip Platform (Hicube).

Development of a self-contained microfluidic chip and an internet-of-things-based point-of-care device for automated identification of respiratory viruses

Portable and simultaneous detection of four respiratory pathogens through a microfluidic LAMP and real-time fluorescence assay

Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants

Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assay

Simultaneous Detection of Multiple Respiratory Pathogens Using an Integrated Microfluidic Chip

High-Throughput and Integrated CRISPR/Cas12a-Based Molecular Diagnosis Using a Deep Learning Enabled Microfluidic System

Detection and identification of SARS-CoV-2 and Influenza A based on microfluidic technology

Rapid Differential Diagnosis of Seven Human Respiratory Coronaviruses Based on Centrifugal Microfluidic Nucleic Acid Assay

Rapid detection of SARS-CoV-2 with CRISPR-Cas12a

Portable all-in-one microfluidic system for CRISPR-Cas13a-based fully integrated multiplexed nucleic acid detection

An automated nucleic acid detection platform using digital microfluidics with an optimized Cas12a system

Point-of-Care Multiplex Detection of Respiratory Viruses

Commercial Strip‐Inspired One‐Pot CRISPR‐Based Chip for Multiplexed Detection of Respiratory Viruses

A compact microfluidic platform for rapid multiplex detection of respiratory viruses via centrifugal polar-absorbance spectroscopy

Multiplexed detection of eight respiratory viruses based on nanozyme colorimetric microfluidic immunoassay

A High-Throughput, Multi-Index Isothermal Amplification Platform for Rapid Detection of 19 Types of Common Respiratory Viruses Including SARS-CoV-2